96 related articles for article (PubMed ID: 8688246)
1. Brain penetration of intrathecal iomeprol in dogs.
La Noce A; Lorenzon P; Pugliese F; Pellecchi G; Orlandini I; Tirone P
Acta Radiol; 1996 Jul; 37(4):578-81. PubMed ID: 8688246
[TBL] [Abstract][Full Text] [Related]
2. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
La Noce A; Bertani F; Lorusso V; Luzzani F; Tirone P; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S43-50. PubMed ID: 8020518
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of iomeprol for injection in experimental animals.
Cipolla P; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan.
Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A
Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258
[TBL] [Abstract][Full Text] [Related]
5. High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400.
Cademartiri F; de Monye C; Pugliese F; Mollet NR; Runza G; van der Lugt A; Midiri M; de Feyter PJ; Lagalla R; Krestin GP
Invest Radiol; 2006 Mar; 41(3):349-53. PubMed ID: 16481919
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue distribution of iomeprol in animals.
Lorusso V; Luzzani F; Bertani F; Tirone P; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S13-20. PubMed ID: 8020515
[TBL] [Abstract][Full Text] [Related]
7. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Morisetti A; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
[TBL] [Abstract][Full Text] [Related]
8. Iomeprol: a review of its use as a contrast medium.
Dooley M; Jarvis B
Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
[TBL] [Abstract][Full Text] [Related]
9. Rate of clearance of intrathecal iopamidol in the dog.
Wilcox J; Evill CA; Sage MR
Neuroradiology; 1986; 28(4):359-61. PubMed ID: 3762917
[TBL] [Abstract][Full Text] [Related]
10. Brain parenchyma penetration by intrathecal nonionic iopamidol.
Sage MR; Wilcox J
AJNR Am J Neuroradiol; 1983; 4(6):1181-3. PubMed ID: 6419558
[TBL] [Abstract][Full Text] [Related]
11. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility and optimization of the combined injection of contrast medium and normal saline with a single-syringe CT injection system].
Raatschen HJ; Albrecht T
Rofo; 2003 Jun; 175(6):844-8. PubMed ID: 12811699
[TBL] [Abstract][Full Text] [Related]
13. Conditioned taste aversion in rats following intrathecal administration of contrast media.
La Noce A; Danieli A; Bertani F; Tirone P; de Haën C
Acta Radiol; 1996 Jan; 37(1):116-20. PubMed ID: 8611314
[TBL] [Abstract][Full Text] [Related]
14. Acute and subacute toxicity studies of ioversol in experimental animals.
Ralston WH; Robbins MS; Coveney J; Blair M
Invest Radiol; 1989 Jun; 24 Suppl 1():S2-9. PubMed ID: 2592169
[TBL] [Abstract][Full Text] [Related]
15. Urine viscosity after injections of iotrolan or iomeprol.
Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Kubo K; Nakashima T
Acta Radiol; 1997 Nov; 38(6):1079-82. PubMed ID: 9394674
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT.
Nebuloni L; Kuhn GA; Müller R
Acad Radiol; 2013 Oct; 20(10):1247-55. PubMed ID: 24029056
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
[TBL] [Abstract][Full Text] [Related]
18. An experimental evaluation of response to contrast media: Pantopaque, iopamidol, and iohexol in the subarachnoid space.
Paşaoğlu A; Gök A; Patiroğlu TE
Invest Radiol; 1988 Oct; 23(10):762-6. PubMed ID: 3192397
[TBL] [Abstract][Full Text] [Related]
19. Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
Lexmaulova L; Zatloukal J; Proks P; Dvorak M; Srnec R; Rauser P; Kecova H; Necas A
J Vet Emerg Crit Care (San Antonio); 2009 Dec; 19(6):611-6. PubMed ID: 20017767
[TBL] [Abstract][Full Text] [Related]
20. Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers.
Chai CM; Karlsson JO; Almén T
Acta Radiol; 2008 Mar; 49(2):150-6. PubMed ID: 18300138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
